Keith Leblanc, MD
MOHS-Micrographic Surgery · Metairie, LANPI 1972765493
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,000 of the $41,072 with a category attached, or 60.9%. Genentech USA, Inc. accounts for 73.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $27,586 and has fallen 98.9% since, to $294 in 2025.
Across 50 payments — averaging $821.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$30K
- Acera Surgical, Inc.$10K
- Mimedx Group, Inc.$348
- Kerecis Limited$199
- Janssen Scientific Affairs, LLC$131
- Organogenesis Inc.$23
What the payments were for
- Speaking & faculty fees$25,00061%
- Travel & lodging$4,75212%
- Food & beverage$1,2393%
- Other$10,08025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 28 | $30,290 |
| Acera Surgical, Inc. | 1 | $10,080 |
| Mimedx Group, Inc. | 14 | $348 |
| Kerecis Limited | 5 | $199 |
| Janssen Scientific Affairs, LLC | 1 | $131 |
| Organogenesis Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erivedge$29,852
- Restrata Wound Matrix$10,080
- Tremfya$131
How this compares
Too few mohs-micrographic surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 126 | $1,732 |
| Mupirocin | 106 | $841 |
| Doxycycline Hyclate | 18 | $88 |
| Amoxicillin | 30 | $41 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Metairie
- Eric FinleyMetairie$1K
- Randall RougelotMetairie$458
- Elizabeth BucherMetairie$442
- Vanessa VossMetairie$396
- Rhonda BaldoneCovington$72K
- Diane TrieuHarvey$15K
- Rachel ReinaCovington$5K
- John ChapmanLafayette$5K
- Caitlin RobinsonMonroe$2K
- Zeena Al DujailiNew Orleans$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.